Correlation Between Avicanna and Aion Therapeutic
Can any of the company-specific risk be diversified away by investing in both Avicanna and Aion Therapeutic at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Avicanna and Aion Therapeutic into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Avicanna and Aion Therapeutic, you can compare the effects of market volatilities on Avicanna and Aion Therapeutic and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Avicanna with a short position of Aion Therapeutic. Check out your portfolio center. Please also check ongoing floating volatility patterns of Avicanna and Aion Therapeutic.
Diversification Opportunities for Avicanna and Aion Therapeutic
-0.26 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Avicanna and Aion is -0.26. Overlapping area represents the amount of risk that can be diversified away by holding Avicanna and Aion Therapeutic in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aion Therapeutic and Avicanna is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Avicanna are associated (or correlated) with Aion Therapeutic. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aion Therapeutic has no effect on the direction of Avicanna i.e., Avicanna and Aion Therapeutic go up and down completely randomly.
Pair Corralation between Avicanna and Aion Therapeutic
Assuming the 90 days horizon Avicanna is expected to under-perform the Aion Therapeutic. But the otc stock apears to be less risky and, when comparing its historical volatility, Avicanna is 15.08 times less risky than Aion Therapeutic. The otc stock trades about -0.01 of its potential returns per unit of risk. The Aion Therapeutic is currently generating about 0.18 of returns per unit of risk over similar time horizon. If you would invest 2.00 in Aion Therapeutic on August 29, 2024 and sell it today you would lose (0.95) from holding Aion Therapeutic or give up 47.5% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Avicanna vs. Aion Therapeutic
Performance |
| Timeline |
| Avicanna |
| Aion Therapeutic |
Avicanna and Aion Therapeutic Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Avicanna and Aion Therapeutic
The main advantage of trading using opposite Avicanna and Aion Therapeutic positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Avicanna position performs unexpectedly, Aion Therapeutic can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aion Therapeutic will offset losses from the drop in Aion Therapeutic's long position.| Avicanna vs. Pharmacielo | Avicanna vs. Khiron Life Sciences | Avicanna vs. Flower One Holdings | Avicanna vs. Cansortium |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Complementary Tools
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Stocks Directory Find actively traded stocks across global markets | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |